Literature DB >> 18551203

Infiltrative lung diseases: complications of novel antineoplastic agents in patients with hematological malignancies.

Bobbak Vahid1, Paul E Marik.   

Abstract

Infiltrative lung disease is a well-known complication of antineoplastic agents in patients with hematological malignancies. Novel agents are constantly being added to available treatments. The present review discusses different pulmonary syndromes, pathogenesis and management of these novel agents.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18551203      PMCID： PMC2677954          DOI： 10.1155/2008/305234

Source DB:  PubMed          Journal:  Can Respir J        ISSN： 1198-2241            Impact factor:   2.409


  101 in total

Review 1.  Pulmonary toxicity of chemotherapy and G/GM-CSF: a report of five cases.

Authors:  L J Couderc; S Stelianides; I Frachon; M Stern; B Epardeau; E Baumelou; I Caubarrere; O Hermine
Journal:  Respir Med       Date:  1999-01       Impact factor: 3.415

2.  Diffuse alveolar hemorrhage following gemtuzumab ozogamicin.

Authors:  T S Lin; S L Penza; B R Avalos; M R Lucarelli; S S Farag; J C Byrd; E A Copelan
Journal:  Bone Marrow Transplant       Date:  2005-04       Impact factor: 5.483

3.  Corticosteroid-responsive interstitial pneumonitis related to imantinib mesylate with successful rechallenge, and potential causative mechanisms.

Authors:  P Grimison; D Goldstein; J Schneeweiss; N Murray
Journal:  Intern Med J       Date:  2005-02       Impact factor: 2.048

4.  Infectious toxicity using alemtuzumab.

Authors:  Annamaria Nosari; Marco Montillo; Enrica Morra
Journal:  Haematologica       Date:  2004-12       Impact factor: 9.941

5.  Reversible drug-induced interstitial pneumonitis following imatinib mesylate therapy.

Authors:  Jay Rajda; Pradyumna D Phatak
Journal:  Am J Hematol       Date:  2005-05       Impact factor: 10.047

6.  Side effects and good effects from new chemotherapeutic agents. Case 2. Thalidomide-induced interstitial pneumonitis.

Authors:  Masahiro Onozawa; Satoshi Hashino; Susumu Sogabe; Masahira Haneda; Hiromasa Horimoto; Koh Izumiyama; Takeshi Kondo; Luis Perez Aldana; Kunio Hamada; Masahiro Asaka
Journal:  J Clin Oncol       Date:  2005-04-01       Impact factor: 44.544

7.  Severe interstitial pneumonitis following rituximab and bleomycin-containing combination chemotherapy.

Authors:  H Ghesquieres
Journal:  Ann Oncol       Date:  2005-04-27       Impact factor: 32.976

8.  Bronchiolitis obliterans organizing pneumonia in a patient with non-Hodgkin's lymphoma following R-CHOP and pegylated filgrastim.

Authors:  C Macartney; E Burke; S Elborn; N Magee; P Noone; I Gleadhill; D Allen; P Kettle; M Drake
Journal:  Leuk Lymphoma       Date:  2005-10

9.  Acute lung injury induced by arsenic trioxide in a patient with refractory myelodysplastic syndrome.

Authors:  Hesham A Hassaballa; Omar B Lateef; Michael R Silver; Robert A Balk
Journal:  J Crit Care       Date:  2005-03       Impact factor: 3.425

10.  Pentostatin (2'-deoxycoformycin) for the treatment of hepatosplenic gammadelta T-cell lymphomas.

Authors:  Gaetano Corazzelli; Gaetana Capobianco; Filippo Russo; Ferdinando Frigeri; Donatella Aldinucci; Antonio Pinto
Journal:  Haematologica       Date:  2005-03       Impact factor: 9.941
View more
  4 in total

1.  Pulmonary complications of transcatheter arterial chemoembolization for hepatocellular carcinoma.

Authors:  Quan M Nhu; Harry Knowles; Paul J Pockros; Catherine T Frenette
Journal:  World J Respirol       Date:  2016-11-28

Review 2.  New drugs, new toxicities: severe side effects of modern targeted and immunotherapy of cancer and their management.

Authors:  Frank Kroschinsky; Friedrich Stölzel; Simone von Bonin; Gernot Beutel; Matthias Kochanek; Michael Kiehl; Peter Schellongowski
Journal:  Crit Care       Date:  2017-04-14       Impact factor: 9.097

3.  Pomalidomide-Induced Pulmonary Toxicity in Multiple Myeloma.

Authors:  Dipenkumar Modi; Hirva Mamdani; Theresa Vettese
Journal:  Am J Med Sci       Date:  2015-09       Impact factor: 2.378

4.  Thin-Section CT Characteristics and Longitudinal CT Follow-up of Chemotherapy Induced Interstitial Pneumonitis: A Retrospective Cohort Study.

Authors:  Han Na Lee; Mi Young Kim; Hyun Jung Koo; Sung-Soo Kim; Dok Hyun Yoon; Jae Cheol Lee; Jin Woo Song
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.